top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

2.060 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,366
Open 2.060
Bid (Size) 1.970 (2,000)
Ask (Size) 2.050 (1,000)
Prev. Close 2.060
Today's Range 2.060 - 2.060
52wk Range 1.790 - 10.99
Shares Outstanding 114,010,448
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
From Pomerantz LLP
Via GlobeNewswire
News headline image
Karyopharm (KPTI) Q2 2026 Earnings Call Transcript ↗
Biotech pivots to hematology after endometrial cancer setback, faces debt deadline. 
Via The Motley Fool
Topics Earnings

Performance

YTD
-71.3%
-71.3%
1 Month
+4.6%
+4.6%
3 Month
-79.0%
-79.0%
6 Month
-78.5%
-78.5%
1 Year
-69.6%
-69.6%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
From Pomerantz LLP
Via GlobeNewswire
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Posts Q1 Beat and Highlights ASCO Presentation, Shares Surge 7% ↗
Via Chartmill
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q4 Revenue Miss and Wider Loss, Stock Falls in Pre-Market ↗
Via Chartmill
News headline image
Earnings Scheduled For November 3, 2025 ↗
Via Benzinga
News headline image
Karyopharm Therapeutics Earnings Preview ↗
Via Benzinga
News headline image
Karyopharm Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript ↗
Via Benzinga
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
From Pomerantz LLP
Via GlobeNewswire
Top movers in Friday's session ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Gapping stocks in Friday's session ↗
Via Chartmill
Friday's pre-market session: top gainers and losers ↗
Via Chartmill
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Karyopharm Therapeutics Spotlights Selinexor Milestones, ASCO Data and Cancer Trial Readouts ↗
Via MarketBeat
News headline image
Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus ↗
Via MarketBeat
News headline image
Karyopharm (KPTI) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Karyopharm Therapeutics Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Karyopharm (KPTI) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Karyopharm (KPTI) Q1 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Registration Momentum Builds Across the Oncology Pipeline
From USA News Group
Via GlobeNewswire
News headline image
Karyopharm (KPTI) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Derivatives Earnings
News headline image
Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q3 2025 Revenue Beat and Earnings Miss ↗
Via Chartmill
Topics Earnings

Frequently Asked Questions

Is Karyopharm Therapeutics Inc. - Common Stock publicly traded?
Yes, Karyopharm Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Karyopharm Therapeutics Inc. - Common Stock trade on?
Karyopharm Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Karyopharm Therapeutics Inc. - Common Stock?
The ticker symbol for Karyopharm Therapeutics Inc. - Common Stock is KPTI on the Nasdaq Stock Market
What is the current price of Karyopharm Therapeutics Inc. - Common Stock?
The current price of Karyopharm Therapeutics Inc. - Common Stock is 2.060
When was Karyopharm Therapeutics Inc. - Common Stock last traded?
The last trade of Karyopharm Therapeutics Inc. - Common Stock was at 08/31/26 04:00 PM ET
What is the market capitalization of Karyopharm Therapeutics Inc. - Common Stock?
The market capitalization of Karyopharm Therapeutics Inc. - Common Stock is 234.86M
How many shares of Karyopharm Therapeutics Inc. - Common Stock are outstanding?
Karyopharm Therapeutics Inc. - Common Stock has 235M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page